In breast cancer, reduced expression of AnxA6 and its tumor suppressor function is more relevant in TNBC than in non-TNBC subtypes [103], an observation that is consistent with the differences in the malignancy of these breast tumors. The gene discussed is ANXA6; the disease is breast neoplasm.